Investigation Of Biochemical Anomalies In People With A Visual Form Of Dyslexia: Implications For Early Identification And Dietary Intervention

G.L. Robinson, T.K. Roberts, N.R. McGregor, E.B. Ellis, H. Dunstan, H. Butt
University of Newcastle, NSW, Australia

Visual Processing Problems and Dyslexia

In the past decade, researchers have investigated and identified a variety of visual processing deficits among individuals with dyslexia (Skottun, 2000; Stein & Talcott, 1999; Valdois, Gerard, Vanault, & Dugas, 1995; Willows, 1998). While the results of these studies do not present a simple picture, visual functioning among dyslexic individuals is now an accepted area of research. One area of investigation has centred upon the proposal by Irlen (1991a) of a specific visual-perceptual dysfunction, which she suggested was related to an excess sensitivity of the retina to particular frequencies of the light spectrum. This dysfunction, which has been called Irlen Syndrome (IS), is unrelated to skills normally assessed by an optometric examination (Evans, Busby, Jeanes, & Wilkins, 1995). Symptoms of IS which are reported while reading or writing include a blurring and shadowing of letters and words, a doubling, merging or movement of print, eye strain and fatigue, a restricted span of focus and problems focussing for an extended period of time (Irlen, 1991a; Meares, 1980).

Retinal malfunction has been implicated as a possible cause of the described symptoms and this claim receives support from a variety of investigations. Grosser and Spafford (1989, 1990) identified extra peripheral cones in the retinas of subjects with dyslexia, as well as a greater sensitivity to light in peripheral vision (Grosser & Spafford, 1990; Spafford & Grosser, 1991). It was hypothesised that this abnormal distribution may lead to letter images in peripheral vision competing with letter images in central vision. Lewine (1999) found that visual evoked responses for subjects with symptoms of IS showed an organised dipolar pattern with coloured filters and a more complex field pattern without them. He speculated that people with dyslexia may have a greater distribution of cones in peripheral areas, leading to some linking of cones with rod nerve systems, which may cause letters and words to appear to move. Irvine and Irvine (1997) identified a number of visual processing deficits related to IS and suggested a variety of possible retinal abnormalities, including signal interference between adjacent receptor cells, abnormalities in receptor distribution, and cones of one colour being attached to the nerve system supporting cones of another colour.

The symptoms described by Irlen (1991a) may also be indicative of a sensory-after imaging effect in which images, such as words, could persist longer for reading disabled than average readers (Shapiro, Raymond, & Arnell, 1994; Willows, 1998). These symptoms could be related to a deficit in the magnocellular visual neurological pathway (Demb, Boynton, Best, & Heeger, 1998; Eden, Van Meter, Rumsey, Maisog, Woods, & Zeffrio, 1996), which may cause an overlapping of visual images between consecutive eye fixations when reading (Solman, Cho, & Dain, 1992; Williams & Lovegrove, 1992), and unstable binocular control (Stein & Talcott, 1999). It has been claimed that magnocellular activation may suppress the overlap of images between eye fixations (saccadic suppression), as well as playing an important part in keeping the two eyes steadily fixed on each word (Stein & Talcott, 1999), and subjects with symptoms of IS have poor eye movements (Robinson & Foreman, 1999a; Solan, Ficarra, Brannan, & Rucker, 1998), and frequently report that letters and words may move, merge and change places (Irlen, 1991a). Studies by Kubova, Kuba, Peregrin, and Novakova (1996), Livingstone, Rosen, Drislane, and Galaburda (1991), and Lehmkuhle, Garzia, Turner, Hash, and Baro (1993) identified diminished or delayed evoked potential for poor readers along the magnocellular pathway. Eden et al. (1996) and Demb, Boynton, and Heeger (1998) found a reduced activation of the V5/MT area of the visual cortex, which is sensitive to visual motion and is dominated by magnocellular input. Colour filtering is claimed to influence the functioning ability of the magnocellular pathway (Edwards, Hogben, Clark, & Pratt, 1996; Solman, Dain, & Keech, 1991; Williams, LeCluyse, & Rock-Faucheux, 1992), and has been reported to reduce symptoms of IS (Irlen & Robinson, 1996; Whiting, Robinson, & Parrot, 1994). The magnocellular hypothesis, however, has been questioned with suggestions that the magnocellular system may be insensitive during saccades (Hulme & Hogben, 1997), or that the magnocellular system, not the parvocellular system is suppressed during saccadic eye movements (Skottun & Parke, 1999). Skottun's (2000) review of studies on contrast sensitivity also found conflicting evidence in regard to the magnocellular deficit theory.

Numerous studies have reported improvements in reading with the use of coloured filters, although it should be emphasised that reported improvements in print clarity may assist learning to read, but are unlikely to lead to the development of word recognition skills without additional reading tuition (Kyd, Sutherland, & McGettrick, 1992; Robinson & Conway, 1994; Robinson & Foreman, 1999b). These studies have reported improvements in reading when using coloured plastic overlays or coloured computer monitors (see Croyle, 1998; Jeanes, Busby, Martin, Lewis, Stevenson, Pointon et al., 1997; Tyrrell, Holland, Dennis, & Wilkins, 1995; Wilkins, Jeans, Pumfrey, & Laskier, 1996; Wilkins & Lewis, 1999), as well as improvements in reading when using coloured lenses (see Good, Taylor, & Mortimer, 1991; Harris & MacRow-Hill, 1999; Irvine & Irvine, 1997; Lightstone, Lightstone, & Wilkins, 1999; Robinson & Conway, 2000; Robinson & Foreman, 1999a, b; Solan et al., 1998).

Visual Processing Problems and Biochemical Anomalies

Another recent area of investigation which has implications for visual processing deficits and dyslexia is the analysis of biochemical anomalies. Rae, Lee, Dixon, Blamire, Thompson, and Styles et al. (1998) identified significant metabolic anomalies in males with symptoms of dyslexia in the left temporal lobe and right cerebellum. The metabolic anomalies in the cerebellum were claimed to be consistent with the hypothesis of a magnocellular deficit, as a major part of the visual magnocellular system projects to the posterior parietal cortex.

A number of studies have also suggested an association between essential fatty acids and visual processing problems in dyslexia (Stordy, 1995; 1998; Makrides, Neumann, Summer, Pater, & Gibson, 1995). Stordy (1995) identified a failure to adapt in the dark among adults and children with dyslexia, which has also been found in subjects with symptoms of IS (Carroll, Mullaney, & Eustace, 1994). Stordy (1995) found that within families, the dietary essential fatty acid intake of members with symptoms of dyslexia was lower than symptom-free family members, and dietary supplementation normalised dark adaptation within one month. A further study (Stordy, 1998) found the use of a fatty acid supplementation for children with dyslexia resulted in claims of improvement in general learning (89%) and speed of reading (74%). Makrides et al. (1995) assessed the visual evoked potential acuities of infants who had diets rich in Docosahexaenoic acid (DHA) and found experimental subjects had higher acuities than the control group placed on a placebo formula, at 16 and 30 weeks of age.

Visual Processing Problems, Biochemical Anomalies and Chronic Fatigue Syndrome (CFS) A number of investigations have identified biochemical anomalies in CFS and the range of symptoms identified for this disability include visual problems and fatigue, which have also been reported by subjects with symptoms of visual dyslexia (as identified by IS). McGregor, Dunstan, Zerbes, Butt, Roberts, and Klineberg (1996a, 1996b), and McGregor, Dunstan, Butt, Roberts, Klineberg, and Zerbes (1997) reported that disturbances in urinary metabolite excretion were correlated with physical and psychological symptoms including photophobia, headaches and trouble concentrating, which are common symptoms of IS. Potaznik and Kozol (1992) and Vedelago (1994) also described symptoms in subjects with CFS which are the same as those identified by subjects with IS, including blurring and shadowing of vision, headaches, eye strain, photophobia, decreased span of recognition of words while reading, and difficulty tracking lines of print. Rosenhall, Johannson, and Orndahl (1987, 1996) found abnormal saccades and disturbed smooth pursuit eye movements in large numbers of CFS patients, and similar symptoms have been identified in subjects with IS (Tyrrell et al., 1995).

The results of the above studies suggest that there is an overlap of symptoms of visual dyslexia (IS) and symptoms of CFS. These studies also implicate biochemical anomalies as a possible causal factor in these symptoms. On the basis of these results, a more detailed analysis of these associations has been instigated. This detailed analysis includes two completed studies and a further study which is in the preliminary stages.

STUDY ONE

Method

The first investigation (Robinson, Roberts, McGregor, Dunstan, & Butt, 1999) involved 143 subjects with CFS who had been identified on a CFS questionnaire as likely to have some symptoms of IS. These subjects all had a metabolic profile of urine samples using gas chromatography and mass spectrometry (McGregor et al., 1996a).

The CFS questionnaire, which was used as the basis for identifying subjects likely to have symptoms of IS, consists of 86 items which assess symptoms in a wide variety of areas, including headaches/migraine, body pain or tenderness, stiffness of joints, depression, lack of motivation, nausea and stomach upset, tiredness or fatigue and stress. Items from the CFS questionnaire considered to be indicative of IS and used as the basis for analysis of biochemical profiles were:

Item 1: Headaches
Item 33: Dislike of strong light or photophobia
Item 55: Trouble concentrating

The urine data (arcsine transformed) and clinical data were analysed using t-tests, Pearson product-moment correlations, multivariant and one-way analysis of variant (MANOVA and ANOVA), and forward stepwise discriminant function or multiple regression analysis. Correction for statistical multiplicity occurred where applicable. Group differences were also assessed using Hotellings T2. These data were processed using Access (Ver.1.1, Microsoft), Excel (Ver.4.0, Microsoft), and Statistica (Ver.4.5, Statsoft, Tulsa).

Results

The areas of significant difference in urinary metabolic profiles for subjects with CFS using the specific symptom areas of light sensitivity, headaches and trouble concentrating are shown in Table 1 below. These results indicate a variety of possible biochemical anomalies, but must be treated with caution as there could be a variety of possible causes for broad descriptive categories such as headaches and lack of concentration.

Table 1
Significant differences in urinary metabolic profiles for subjects with CFS in the specific symptoms are of light sensitivity, headaches and trouble concentrating (N=143)

Table 1

Significant anomalies were found in excretion of a number of amino and organic acids, including markers of protein turnover (leucine, proline, 3-methylhistidine) and catecholamine production (tyrosine, phenylalanine). These anomalies suggested that an alteration in protein and tissue metabolite turnover may be associated with the alteration in visual function. Increases in post-viral tissue turnover can also result in a dysregulation of fatty acid distribution and studies by Stordy (1995, 1998), Makrides et al. (1995), and Stevens, Zentall, Abate, Kuczek, and Burgess (1996) have suggested an association between essential fatty acid anomalies and visual problems in dyslexia.

STUDY TWO

While the results of Study One need to be seen as a very tentative first investigation, they did provide further evidence of the potential association between biochemical anomalies and visual difficulties as identified in people with CFS. Study Two extended this investigation by undertaking a full screening of symptoms of IS in subjects with CFS, as well as an analysis of serum lipids and amino organic acids.

Method

A total of 61 adults were identified from the University of Newcastle CFS patient database and screened for symptoms of IS using the Scotopic Sensitivity Syndrome Screening Manual (Irlen, 1991b), with 38 subjects identified to have moderate to high symptoms and 23 identified to have no symptoms or marginal symptoms. In this study a rating of degree of severity of symptoms also occurred as part of section 3 of the screening battery, as well as rating of the degree of improvement when using coloured overlays. These ratings occurred for four areas of symptoms: a) eye strain/fatigue/headaches while reading; b) print distortions/clarity while reading; c) photophobia/light sensitivity while reading, and d) reading speed/errors while reading/duration of reading. The rating sheet used is outlined in Appendix A.

The study subjects all had a metabolic profile of urine samples using gas chromatography and mass spectrometry (GC-MS). All subjects completed a collaborative pain research unit (CPRU) symptom questionnaire. They had previously collected a first morning urine specimen as part of other studies by the method described in McGregor et al. (1996a). Ten ml of whole blood was also collected from the study subjects who had fasted (12 hours) by venipuncture into a lithium heparin vacu-tainer (Becton Dickinson) and processed using a Hewlett Packard 5890 series II gas chromatograph and series 5971A Mass Selective Detector (McGregor et al., 1996). Symptom responses and metabolites were compared using Mann-Whitney U-test and Spearman rank-order correlation (non-parametric data), student t-tests and multiple regression and discriminant function analyses (parametric data).

Results

Factor analysis divided the study subjects into two groups according to degree of symptoms of IS, with one group having a high level of symptoms of IS (N=31), and the other group having a low level of symptoms of IS (N=30). There was no difference in age or sex between the high symptom group (Mean age=49.2, sd=16.5 years; females=71.0%) and the low symptom group (Mean age=52.7, sd=11.3 years; females=54.0%). There was an increased mean degree of visual processing defects reported in the high symptom group compared with the low symptom group (Eye strain/Fatigue/Headaches: High group mean=2.5, sd=0.8, Low group mean=0.7, sd=0.06, P<0.000000002; Print distortion: High group mean=2.8, sd=0.8, Low group mean=1.0, sd=0.08, P<0.000000005; Photosensitivity: High group mean=2.5, sd=0.9, Low group mean=0.7, sd=0.08, P<0.000008, Speed Errors: High group mean=2.5, sd=0.8, Low group mean=0.7, sd=0.09, P<0.00000003).

The two factor analysis groups with high or low levels of symptoms of IS were assessed for the prevalence of other symptoms using their scalar responses to the 86 items on the CPRU questionnaire. Table 1 shows the odds ratios for the assessment of symptom prevalence difference between the two groups; both for ratings of severity of symptoms of IS and degree of improvement of symptoms using coloured filters. While there were a variety of symptoms in which the two groups were different, of particular note are the recurring indicators of infection (sore or swollen lymph nodes in groin and neck).

Table 1
Odds ratio of difference in prevalence of symptoms of CFS between high and low symptom IS groups according to severity of symptoms and response to colour

Table 1

The two factor analysis groups with high or low levels of IS symptoms were assessed for variation in blood lipids and urine amino and organic acids. Table 2 shows the areas of significant difference in lipid and urine components between high and low symptom IS groups according to a) indications of severity of symptoms of IS, and b) assessment of degree of improvement with coloured filters. The mean relative abundance and concentrations are summarised, together with the results of multivariate and univariate analysis.

Table 2
Differences in lipid and urine microbiology between low and high symptom IS groups according to severity of symptoms and response to colour

Table 2

There was an increased level in three lipid and two urine components and a reduced level in three lipid and one urine component for subjects with high symptoms of IS. There was an increased urinary excretion of the connective tissue amino acids, proline and hydroxyproline, and a decrease in the actin-degradation amino acid, 3-methylhistidine. In addition the dietary derived fatty acid trans-9-C18:1 or elaidic acid, which has been linked to macular degeneration of the eye (Hammond, Fuld, & Snodderly, 1996) and alteration in membrane functions, was increased in the subjects with high symptoms of IS, who responded positively to coloured lens use. Palmitoleic acid (cis-9-C16:1), which is also implicated in the facilitation of neural functioning, was also increased in the high symptom IS subjects who responded positively to coloured lens use. Similarly the sterols, cholesterol and lathosterol, so important for proper membrane stability and function, were increased in the high symptom IS group.

It should be noted that the ratings of severity of symptoms of IS are more associated with the connective tissue turnover amino acids (see Table 2, hydroxyproline, proline), while ratings of response to the use of colour are more associated with alteration in lipid components that may alter membrane structure or function (see Table 2, trans-9-C18:1, cis-9-C16:1). It would therefore appear that these two effects may be biochemically different, with the coloured lenses appearing to reduce symptoms associated with membrane changes, which are not related to the underlying increase in tissue turnover.

STUDY THREE

Preliminary studies have identified possible markers, but a larger scale study of people who only have symptoms of IS is needed to replicate these results and to allow a more detailed analysis of biochemical profiles. Identification of the possible biochemical basis for IS would allow early identification and the use of treatment strategies based on underlying causes rather than symptoms (such as attention and behaviour problems). Appropriate treatment provided at an early age is also likely to avoid the development of literacy problems.

The purpose of Study Three is to investigate subjects who have symptoms of visual processing problems (IS) but not symptoms of CFS. This study is also investigating children as well as adults. It was intended that preliminary results would be available by the time of this conference, but the obtaining of ethics approval for sampling of blood from children was a more lengthy process than anticipated.

Research Plan, Methods and Techniques

The research will involve 40 subjects with symptoms of IS and 40 age- and sex-matched subjects with no symptoms of IS. The subjects will be 10 years or above in age and will be taken from people referred to the Special Education Centre, University of Newcastle for reading and writing problems. The subjects will all be required to provide a blood sample, as well as a first morning urine sample. All subjects would also be asked to list the drugs and naturopathic remedies taken and dietary changes that they had made during the preceding 4 weeks. The age- and sex-matched subjects with no symptoms of IS will be recruited primarily from people attending the Special Education Centre for diagnosis of learning disabilities, but also from relatives of the IS subjects.

Molecular analysis will involve the metabolic profiling of urine samples and blood plasma lipids using gas chromatography and mass spectrometry (GCMS). The chemical data and data relating to specific symptoms of IS will be analysed using t-tests, multivariant and one-way analysis of variance (MANOVA and ANOVA) and forward stepwise discriminant function or multiple regression analysis.

Expected Outcomes

Identification of a biochemical basis for the specific symptoms of IS would be expected to have the following outcomes:

  1. It would help establish the validity of the Syndrome as a visual-perceptual sub-type of dyslexia.
  2. It would lead to more effective treatment strategies based on underlying causes rather than behavioural symptoms such as motivation and attention problems.
  3. It would allow early identification.
  4. Early diagnosis would also allow professionals to better inform parents of the likely implications of this disability for literacy and learning difficulties.

Identification of biochemical anomalies would in particular allow a much earlier identification of children with symptoms of IS, and help contribute to a more accurate identification. Early diagnosis is important for the 10% to 20% of the school population with a reading difficulty, as lack of early reading success can lead to discouragement, a passive learning style and further failure (Wong, 1986). If identification of literacy problems is left until significant failure occurs, then the academic gap between failing students and their peers may be too great to overcome.

DISCUSSION

The identification in the two completed studies of a significant number of adults with symptoms of CFS who also have visual processing problems corresponds with the findings of other studies that found visual processing anomalies in adults with CFS. Many of the symptoms described in adults with CFS are the same as those described by people with IS (Robinson et al., 1999; Potaznik & Kozol, 1992; Rosenhall et al., 1987, 1995; Vedelago, 1994).

The alterations in urinary excretion of amino acids, such as hydroxyproline, proline and 3-methlyhistidine, along with increases in lymph node symptoms, support the hypothesis that this dysregulation of protein and tissue turnover may be causally related to an infective agent and an activation of the immune system resulting in visual dysfunction. There have been anecdotal reports from patients in this study of vision improvement following the use of amino acid supplements and/or antibiotic treatment of co-morbid bacterial problems.

The differences in Study Two between IS and non-IS groups in trans-9-C18:1 and cis-9-C16:1 may indicate macular degeneration of the eye which may be reflected in the unstable eye movement noted in people with IS (Robinson & Foreman, 1999a; Solman et al., 1998). Stein and Talcott (1999) report that eye movement control for many dyslexics is mildly impaired such a problem could lead to reports of words moving around the page and appearing to merge, as is reported with symptoms of IS. Biscaldi, Gezeck, and Stuhr (1998) also found a significant correlation between poor eye movement control and dyslexia. The differences in trans-9-C18:1 and cis-9-C16:1 between the IS groups may also be indicative of problems in neural functioning. Delays in visual evoked potential along the magnocellular visual neural pathway have been identified in poor readers and in subjects with IS (Lewine, 1999).

The data from these studies suggest that a complex array of biochemical changes are associated with alteration in vision difficulties in the CFS subjects. The data suggests that these changes may be driven by a pathogen (infective agent). However, the host's response to the pathogen are likely to vary and would be under the control of the host genetics and/or other environmental influences. These preliminary data represent only in the beginning of understanding of a wide range of disabilities, which at the moment are subsumed under broad diagnostic categories such as dyslexia, specific learning disabilities, ADHD, dyspraxia and CFS. Comings (1996) and McCrone (1998), for example, suggest that a variety of biochemical anomalies are likely to be implicated in learning and behaviour problems, and various combinations of these anomalies may cause a variety of overlapping disabilities. It is further claimed (Comings, Wu, Chiu, Ring, Dietz, & Muhleman, 1996) that the underlying cause may be genetic and there may be an additive effect, with a number of genes affecting a range of neurotransmitters. The possibility of overlapping categories of diagnosis for a variety of disabilities has also been put forward by Cohen (1994), Rasmussen and Gillberg (1999), and Anderson (1997). As causal mechanisms for these disabilities become better understood, it is likely that the wide range of symptoms described by each of these broad diagnoses will be broken down into numerous sub-categories, or even separate diagnostic entities, each related to a few specific symptoms that have a common biological/biochemical basis.

The analysis of biochemical anomalies could be particularly important in the development of more valid diagnostic categories. Such an analysis would go beyond observed behavioural symptoms currently used for diagnosis, to investigate underlying (and possibly common) causal mechanisms. It offers the hope that in time we may be able to develop a biochemical profile of each individual, and this profile will allow us to effectively identify which individuals are likely to have specific difficulties in certain learning/social situations, and to provide appropriate treatment. Biochemical analysis may be particularly important for identifying those symptoms which are the cause of the disorder as distinct from those which are the result of the disorder (Pennington, 1989). It is important that treatment strategies are based on causes rather than on overt behavioural symptoms or responses. With current diagnostic categories, the behavioural symptoms for "non-visible disabilities", such as IS, ADD or CFS, are predominantly treated as the cause, with patients being extorted to "try harder" or "concentrate more", which is likely to have a minimal effect if they cannot concentrate (ADHD), feel fatigued (CFS), or have eye strain and a progressive distortion of print while reading (IS). A preliminary investigation of biochemical profiles in people with symptoms of Autism, ADHD and CFS has begun at the Department of Biological Studies, University of Newcastle, Australia. The investigation was initiated in collaboration with a local medical clinician who assessed plasma fatty acids and urinary organic acids in people with a variety of disabling conditions, in order to formulate management plans. Sufficient numbers of subjects have been reviewed extensively to initiate multivariate statistical analysis in conjunction with data obtained from other studies. It was found that the three groups with disabilities all had clearly different biochemical profiles. All three groups were also clearly different from a control group with no disabilities.

The development of more effective diagnostic categories through biochemical analysis could also allow a rational evaluation of the most effective treatment strategies. The broad diagnostic categories currently used are likely to result in a variety of disabilities, or sub-groups of a disability, being present in any one study population (Torgesen, 1998). As a consequence, when researchers attempt to compare findings, they are frequently conflicting, due to patient group heterogeneity.

Dietary Intervention as a Possible Treatment Option?

The identification of dysregulated metabolism in people with symptoms of IS raises the question of dietary manipulation and food supplementation as an addition to the already established treatments of tinted filters and remedial support. The dysregulation of amino/organic acid excretion, indicating a dysregulation in tissue turnover and the dysregulation of fatty acid homeostasis, appear related to a post-infection aetiology. There have been anecdotal reports from subjects in this study that vision has improved with the use of amino acid supplements and following antibiotic treatment. Knivesberg's (1997) analysis of the urine samples of 15 dyslexics and 15 age and sex matched controls also found more abnormalities in urine patterns, higher peptide levels and more frequently occurring immune disorders.

Dietary intervention for people with dyslexia has been successfully undertaken by Stordy (1995, 1998) and Makrides et al. (1995) using an essential fatty acid supplementation. The data from Study Two implicates an infectious challenge and its resultant immune dysfunction as the possible cause of these fatty acid changes. Hammond et al. (1996) identified individual differences in macular pigment density, which they suggested was be related to age-related macular degeneration of the eye. Macular degeneration has been linked to diet, with individuals who have a low intake of antioxidant-rich foods having a higher risk of macular degeneration (Goldberg, Flowerdew, Smith, Brody, & Tso, 1988). In Study Two there was an increase in the dietary fatty acid, trans-9-octadecenoic acid (elaidic acid), the accumulation of which has been suggested to be associated with macular degeneration.

There have been a variety of other investigations that implicate diet as a potentially important aspect of treatment for people with learning disabilities. Benton (1997) reported a case study in which a glyconutritional supplement, given to a child with dyslexia, resulted in claims of large improvements in reading and writing activities. Dietary intervention has also been shown to have a positive effect for people with ADHD (Boris & Mandel, 1994; Carter, Urbanowicz, Hemsley, Mantilla, Strobel, Graham, & Taylor, 1993; Egger, Carter, Graham, Gumley, & Soothill, 1985; Egger, Stoller, & McEwen, 1993; Knivesberg, Nødland, Reichelt, & Fosse, 2000; Uhlig, Merkenschlager, Brandmaier, & Egger, 1997). Uhlig et al. (1997) found a significant increase in beta brain electrical activity following the ingestion of previously identified provoking foods. Knivesberg et al. (2000) reported on the evaluation of a casein free diet for children with symptoms of ADHD and additional urinary peptide anomalies. Preliminary data has identified a significant reduction in peptide levels, as well as significant improvements in behaviour. Carter et al. (1993) found a significant worsening in ratings of behaviour and in psychological test performance for provoking foods using blinded crossover design. Boris and Mandel (1994), and Egger et al. (1985) used elimination diets to identify those subjects who responded favourably and then challenged the responders with a variety of foods in a placebo-controlled and blinded study. In both cases, there were significant improvements in behaviour on placebo days compared to challenge days. Egger et al. (1993) obtained positive results for a food desensitisation technique using a double-blind, placebo-controlled trial.

There have also been studies of successful dietary intervention for children with symptoms of autism, and reading problems are more frequent than expected in families with autism (Le Couteur, 1988). Increased levels of peptides have been found in urine analyses (Cade, Privette, Fregly, Rowland, Sun, Zele, Wagemaker, & Edelstein, 2000; Knivsberg, Reichelt, & Nødland, 1999; Knivsberg, Reichelt, Nødland, & Høien, 1995; Reichelt, Knivsberg, Nødland, Stensrud, & Reichelt, 1997), some of which may stem from dietary proteins (Reichelt, Ekrenn, & Scott, 1990; Shattock, Kennedy, Rowell, & Berney, 1990). When autistic subjects in the Knivsberg et al. (1995) study were provided with a diet free of gluten and milk proteins, there was a normalisation of urine patterns and peptide levels within one year and significant improvements in social, cognitive, and communicative skills in a four year follow-up. Those subjects who stopped the diet regressed. Reichelt et al. (1990) also found a normalisation of peptide patterns and improvement in social skills after one year of a similar dietary intervention, while Knivsberg et al. (1999) obtained a similar result over two years of intervention and Cade et al. (2000) after three months of intervention. Other studies have also found a reduction in symptoms of autism following dietary changes (Knivsberg, Reichelt, Høien, & Nødland, 1998; Whiteley, Rodgers, Savery, & Shattock, 1999). Preliminary investigations at the University of Newcastle, Australia, have identified altered urinary amino acid and blood lipid profiles which can be influenced by dietary supplementation. There were also increases in long chain fatty acids indicative of poor intracellular processing of these lipids and supplementation with essential fatty acids could be beneficial. Analyses of faecal bacteria indicated that important gut bacteria are often lacking, and sometimes almost absent, with treatment to normalise this bacteria having beneficial results.

A greater understanding of biochemical anomalies may result in dietary intervention being a useful supplement to other treatment procedures. How dietary essential fatty acid relates to alterations in body levels of trans-9-octadecenoaic (elaidic) acid is yet to be determined. The most immediate needs would be to identify whether changes in diet lead to changes in biochemical profiles and to changes in symptoms, as well as to explore how dietary essential fatty acid may relate to alterations in body levels of trans-9-octadeceoaic (eliadic) acid. It would also be interesting to explore whether dietary intervention leads to changes in neural responses, as identified by Uhlig et al. (1997) in relation to dietary changes for children with ADHD.

Possible Immune System Deficiencies?

It has been claimed that there may be an immunological basis for learning problems. These immune mechanism changes may follow two potential mechanisms: 1) in-utero and/or genetic immune changes effecting development; and 2) viral infection induced changes.

In-utero mechanisms are based upon the observation that antigens in the maternal circulation can cross the placental barrier and influence the organisation, migration and subsequent connectivity of neurons (Duane, 1991), thus altering central nervous system structure and consequent physiology, chemistry and function. Humphries, Kauffman, and Galaburda (1990) hypothesised that the finding of fibromyelin plaques in dyslexic subjects may be the result of central nervous system circulation alterations occurring in the last trimester of foetal development or prior to postnatal year two.

Pennington, Smith, Kimberling, Green and Haith (1987) found elevated levels of antibodies in mothers with dyslexic children, and Lahita (1988) found mothers with a particular immune system disability had a higher than average rate of children with learning disorders. Stein and Talcott (1999) and Galaburda (1997) cite evidence that dyslexics and their families have a greater than normal incidence of autoimmune disorders, and a number of other authors have reported an association between immune disorders and dyslexia (Armstrong, Seidel, & Swales, 1993; Bulmer, 1994; Geschwind & Behan, 1982; Hugdahl, 1995; Knivsberg, 1997; Wood & Cooper, 1992). Chronic Fatigue Syndrome has also been associated with a variety of immune system deficiencies (Dykman, Tone, & Dykman, 1997; Ojo-Amaize, Conley, & Peter, 1994), as well as dysregulation of immune cell numbers and cytokine production (Gupta & Vayevegula, 1991).

The possible association between CFS, visual/ocular problems and immune system dysfunction was also observed in Study Two. The changes in reading ability and response to lens use were associated with indicators of infection as shown by sore or swollen lymph nodes (Table 1), as well as dysregulation of urinary metabolites and fatty acid metabolism, which may be indicative of a reaction to infection (Table 2) (Arao, Soushi, Sato, Moriishi, Audo, Yamada, Padilla, Uno, Nii, & Kurata 1997; Qavi, Xu, Green, Lusso, Pearson, & Ablashi 1996; Robinson et al., 1999; Singh, Ling, & Yang, 1998).

One possible reason for this reaction to infection for people with CFS relates to the T-helper response. T-helpers are concerned with the activation of the immune system. T-helper 1 is responsible for the development of antibodies to combat bacteria within the cell (intercellular). T-helper 2 is responsible for the development of antibodies which combat bacteria outside the cell (extracellular). It could be hypothesised that some intercellular bacteria may evade the host immune system by causing it to activate a T-helper 2 (extracellular) response instead of a T-helper 1 (intracellular) response. All of the organisms which cause problems with CFS are organisms which cause a T-helper 2 response. In this response, a large amount of release of Interlukin 1, Interlukin 6 and Interlukin 8 occurs. Interlukin 6 is responsible for the induction of regulated cell suicide (apoptosis). It does this by activating the Caspase Cascade which is a sequential activation of a variety of enzymes, with one being the proteolytic enzyme Caspase 3. Caspase 3 acts on the antiviral enzyme RNaseL, which has been induced in the cell to protect it from viral replication. The Caspase 3 enzyme cleaves a small internal section from the RNaseL enzyme and the resulting enzyme lacks the binding site for the RNaseL inhibitor which is used to stop the reaction to viral infection. As it does not have an inhibitor, the enzyme is far more active than the original and the host cell is not able to replenish its normal proteins, thus contributing to the fatigue state.

The high familial incidence of disabilities such as IS (Robinson, Foreman, & Dear, 1996) suggest that a gene mechanism may influence the probability of immune system dysfunction. However, while familial gene traits may influence the probability of familial reading difficulties, the possibility of familial transfer of infective agents is also a distinct possibility. While viruses such as Human Herpes-6 (HHV-6) are not transferred across the placenta, children usually contract HHV-6 infections in the first couple of years of life from other family members. This is important as reactivation of HHV-6 has also been implicated in the development of CFS (Suhadolnik, Reichenbach, Hitzges, Sobow, Peterson, Henry et al., 1994; Suhadolnik, Peterson, O'Brien, Cheney, Herst, Reichenbach et al, 1997). This virus may also play some role in alteration of retinal function. Qavi et al. (1996) showed that HHV-6 was able to infect corneal epithelial cells, whilst Arao et al. (1997) also showed that HHV-6 was able to infect retinal pigment epithelial cells. Significantly, Singh et al. (1998) reported that HHV-6, along with an autoantibody against neuron-axon filament protein, was increased in patients with autism. Thus the alteration in visual processing may be associated with a persistent viral infection by HHV-6.

CONCLUSION

There is growing evidence of a biochemical basis for a visual processing sub-type of dyslexia. There are, however, many questions which remain unanswered, and a great deal of further research is clearly needed if we are to determine the place of biochemical anomalies as an underlying causal mechanism. This task is made harder because of the complex interaction between underlying causes and environmental influences. Different experiences in relation to home and school support, as well as differences in the amount and type of exposure to remedial intervention, may result in very different behavioural symptoms for similar underlying causes. Environmental influences may also be an important factor in the success of any potential dietary management (Carter et al., 1993; Egger et al., 1985), especially at school where trading of foods and purchase of snacks may occur (Boris & Mandel, 1994). It has also been suggested that biochemical anomalies and/or neural malfunction may operate in a reciprocal causation cycle (Stein & Talcott, 1999), with changes in brain biochemistry leading to alterations in neural functioning, which could lead to further changes in neural functioning. We are only just beginning to recognise and accept the existence of a number of learning and behaviour difficulties, and only just beginning to be aware of the complexity of causal mechanisms and of the complexity of providing effective intervention strategies.

REFERENCES

Anderson, V. (1997). Attention deficit-hyperactivity disorder: Neuropsychological theory and practice. In J. Bailey & D. Rice (Eds.), Attentional Deficit/Hyperactivity Disorder: Medical, psychological and education perspectives. Sydney: Australian Association of Special Education Inc.

Arao, Y., Soushi, S., Sato, Y., Moriishi, E., Ando, Y., Yamada, M., Padilla, J., Uno, F., Nii, S., & Kurata, T. (1997). Infection of a human retinal pigment epithelial cell line with human herpes virus 6 variant A. Journal of Medical Virology, 53, 105-110.

Armstrong, F.D., Seidel, J.F., & Swales, T.P. (1993). Pediatric HIV infection: A neuropsychological and educational challenge. Journal of Learning Disabilities, 26, 92-103.

Barker, T.A., Torgesen, J.K., & Wagner, R.K. (1992). The role of orthographic processing skills on five different reading tasks. Reading Research Quarterly, 27(4), 335-345.

Benton, D.J. (1997). Case report: Observed improvements in developmental dyslexia accompanied by supplementation with glyconutritionals and phytonutritionals. Journal of the American Neutraceutical Association, Supplement 1, 13-14.

Biscaldi, M., Gezeck, S., & Stuhr, V. (1998). Poor saccadic control correlates with dyslexia. Neuropsychologica, 36(11), 1189-1202.

Boris, M. & Mandel, F.S. (1994). Foods and additives are common causes of the attention deficit hyperactive disorder in children. Annals of Allergy, 72, 462-468.

Cade, R., Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele, V., Wagemaker, H., Edelstein, C. (2000). Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience, 3, 57-72.

Carroll, T.A., Mullaney, P., & Eustace, P. (1994). Dark adaptation in disabled readers screened for Scotopic Sensitivity Syndrome. Perceptual and Motor Skills, 18, 131-141.

Carter, C.M., Urbanowicz, M., Hemsley, R., Mantilla, L., Strobel, S., Graham, P.J., & Taylor, E. (1993). Effects of a few food diet in attention deficit disorder. Archives of Disease in Childhood, 69, 564-568.

Cohen, J. (1994). On the differential diagnosis of reading, attentional and depressive disorders. Annals of Dyslexia, 44, 165-184. Chronicle, E.P. & Wilkins, A.J. (1991). Colour and visual discomfort in migraineurs. The Lancet, 338, 890.

Comings, D. (1996). New genetic findings show ADHD is not a myth. Adult ADD conference: Bringing the Pieces Together. Ann Arbour, Michigan, 16-18 May.

Comings, D., Wu, H., Chiu, C., Ring, R., Dietz, G., & Muhlemann (1996). Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: The additive and subtractive effect of three dopaminergic genes - DRD2, D_H and DAT1. American Journal of Medical Genetics (Neuropsychological Genetics), 67, 264-288.

Croyle, L. (1998). Rate of reading, visual processing, colour and contrast. Australian Journal of Learning Disabilities, 3(3), 13-20.

Demb, J.M., Boynton, G.M., Best, M., & Heeger, D.J. (1998). Psychophysical evidence for a magnocellular pathway deficit in dyslexia. Vision Research, 38(11), 1555-1559.

Demb, J.M., Boynton, G.M., & Heeger, D.J. (1998). Functional magnetic resonance imaging of early visual pathways in dyslexia. Journal of Neuroscience, 18(17), 6939-6951.

Duane, D.D. (1991). Biological foundations of learning disabilities. In J.E. Obrzut & G.W. Hynd (Eds.), Neuropsychological foundations of learning disabilities (pp.7-21), New York: Academic Press.

Dykman, K., Tone, C., & Dykman, R. (1997). Analysis of retrospective survey on the effects of nutritional supplements on chronic fatigue syndrome and/or fibromyalgia. Journal of the American Neutraceutical Association, Supplement 1, 28-31.

Eden, G.F., Van Meter, J.W., Rumsey, J.M., Maisog, J.M., Woods, R.P., & Zeffrio, T.A. (1996). Abnormal processing of visual motion in dyslexia revealed by functional brain imaging. Nature, 382, 66-69.

Egger, J., Carter, C.M., Gumley, D., Graham, P.J., & Soothill, J.F. (1985). Controlled trial of oligoantigenie treatment in the hyperkinetic syndrome. The Lancet, 1, 540-545.

Egger, J., Stolla, A., & McEwen, L. (1992). Controlled trial of hyposensitisation with food-induced hyperkinetic syndrome. The Lancet, 339, 1150-1153.

Edwards, V.T., Hogben, J.H., Clark, C.D., & Pratt, C. (1996). Effects of a red background on magnocellular functioning in average and specifically disabled readers. Vision Research, 36(7), 1037-1045.

Ehri, L.C. (1989). The development of spelling knowledge and its role in reading acquisition and reading disability. Journal of Learning Disabilities, 22, 356-365.

Foorman, B.R. & Liberman, B.R. (1989). Visual and phonological processing of words: a comparison of good and poor readers. Journal of Learning Disabilities, 22, 349-355.

Galaburda, A.M. (1997). Neurobiology of developmental dyslexia: Results of a ten year research program. Learning Disabilities: A Multidisiplinary Journal, 8(1), 45-50.

Goldberg, J., Flowerdew, G., Smith, E., Brody, J.A., & Tso, M.O.M. (1988). Factors associated with age related macular degeneration: An analysis of data from the First National Health and Nutrition Survey. American Journal of Epidemiology, 128, 700-710.

Good, P.A., Taylor, R.H., & Mortimer, M.J. (1991). The use of tinted glasses in childhood migraine. Headache, September, 533-536.

Grosser, G.S. & Spafford, C.S. (1989). Perceptual evidence for and anomalous distribution of rods and cones in the retinas of dyslexics: A new hypothesis. Perceptual and Motor Skills, 68, 683-698.

Grosser, G.S. & Spafford, C.S. (1990). Light sensitivity in peripheral retinal fields of dyslexic and proficient readers. Perceptual and Motor Skills, 71, 467-477.

Gupta, S. & Vayevegula, B. (1991). A comprehensive immunological analysis of chronic fatigue syndrome. Scandinavian Journal of Immunology, 33(3), 319-327.

Hammond, B.R., Fuld, K., & Snodderley, D.M. (1996). Iris color and macular pigment optical density. Experimental Eye Research, 62, 293-297.

Harris, D. & MacRow-Hill (1999). Application of Chroma-Gen haloscopic lenses to patients with dyslexia: A double-masked placebo-controlled trial. Journal of the Optometric Association, 70(1), 629-640.

Hugdahl, K. (1995). Psychophysiology: The mind-body perspective. Cambridge, MA: Harvard University Press.

Hulme, C. & Hogben, M.J. (1997). How does a visual transient deficit affect reading? In C. Hulme & M. Snowling (Eds.), Dyslexia: Biology, cognition and intervention. (pp.59-70). London, UK: Whurr

Humphries, P., Kaufmann, W.E., & Galaburda, A.M. (1990). Developmental dyslexia in women: Neuropathological findings in three cases. Annals of Neurology, 28, 86-95.

Irlen, H. (1991a). Reading by the colors. New York: Avery. Irvine, J.H. & Irvine, E.W. (1997). Scotopic Sensitivity Syndrome in a single individual (a case study). Naval Air Warfare Centre, Weapons Division, China Lake, California, April.

Kaplan, B.J., McNicol, J., Conte, R.A., & Moghadam, H.K. (1989). Dietary replacement in preschool-aged hyperactive boys. Pediatrics, 83, 7-17.

Knivsberg, A. (1997). Urine patterns, peptide levels and IgA/IgG antibodies to food proteins in children with dyslexia. Pediatric Rehabilitation, 1(1), 25-33.

Knivsberg, A., Nødland, M., Reichelt, K.L., & Fosse, K. (2000). Dietary intervention for 15 children with hyperactivity. Conference Proceedings. Biological Perspectives on Autism, University of Durham.

Knivsberg, A., Reichelt, K.L., & Nødland, M. (1999). Dietary intervention for a seven year old girl with autistic behavior. Nutritional Neuroscience, 2, 435-439.

Knivsberg, A., Reichelt, K.L., Nødland, M., & Høien, T. (1995). Autistic syndromes and diet: A follow-up study. Scandinavian Journal of Educational Research, 39(3), 223-236.

Knivsberg, A., Reichelt, K.L., Høien, T., & Nødland, M. (1998). Parents observations after one year of dietary intervention for children with autistic syndromes. In Psychobiology and autism: Current research and practice. Sunderland: University of Sunderland & Autism North Ltd, 13-24.

Kubova, Z., Kuba, M., Peregrin, J., & Novakova, V. (1996). Visual evoked potential evidence for a magnocellular system deficit in dyslexia. Physiological Research, 45(1), 87-89.

Lahita. R.G. (1988). Systematic lupus erythematosis: Learning disability in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology, 13, 385-396.

Le Couteur, A. (1988). The role of genetics in the aetiology of autism, including findings of the links with the Fragile X syndrome. In L. Wing (Ed.), Aspects of autism: Biological research. (pp.38-52). London: Gaskell.

Lehmkuhle, S., Garzia, R.P., Turner, L., Hash, T., & Baro, J.A. (1993). A defective visual pathway in children with reading disability. New England Journal of Medicine, 328, 989-996.

Lewine, J.D. (1999). Changes in visual evoked magnetic field for people with SSIS. Fourth Biannual Australasian Irlen Conference. Newcastle, Australia, May 20-22.

Lightstone, A., Lightstone, T., & Wilkins, A.J. (1999). Both coloured overlays and coloured lenses can improve reading fluency, but their optimal chromacities differ. Ophthalmological and Physiological Optics, 19(4), 279-285.

Livingstone, M.S., Rosen, G.D., Drislane, F.W., & Galaburda, A.M. (1991). Physiological and anatomical evidence for a magnocellular defect in developmental dyslexia. Proceedings of the National Academy of Science USA, 88, 7943-7947.

McCrone, P. (1998). Investigating the causes of autism. New Scientist, 20 June, 43-45.

McGregor, N.R., Dunstan, R.H., Zerbes, M., Butt, H.L., Roberts, T.K., & Klineberg, I.J. (1996a). Preliminary determination of a molecular basis to Chronic Fatigue Syndrome. Biochemical and Molecular Medicine, 57, 73-80.

McGregor, N.R., Dunstan, R.H., Zerbes, M., Butt, H.L., Roberts, T.K., & Klineberg, I.J. (1996b). Preliminary determination of the association between symptom expression and urinary metabolites in subjects with Chronic Fatigue Syndrome. Biochemical and Molecular Medicine, 58, 85-92.

McGregor, N.R., Dunstan, R.H., Butt, H.L., Roberts, T.K., Klineberg, I.J., & Zerbes, M. (1997). A preliminary assessment of the association between scc-90-R psychological inventory responses with changes in urinary metabolites in patients with Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, 3(1), 17-37.

Makrides, M., Neumann, M., Summer, K., Pater, J., & Gibson, R. (1995). Are long-chain polyunsaturated fatty acids essential nutrients in infancy? The Lancet, 345, 1463-1468.

Ojo-Amaize, E.A., Conley, E.J., & Peter, J.B. (1994). Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome. Clinical Infectious Diseases, 18 (Supplement), 157-159.

Pennington, B.F. (1989). Using genetics to understand dyslexia. Annals of Dyslexia, 39, 81-91. Pennington, B.F. (1991). Diagnosing learning disorders. New York: Guilford Press.

Pennington, B.F., Smith, S.D., Kimberling, W.J., Green, P.A., & Haith, M.M. (1987). Left-handedness and immune disorders in family dyslexics. Archives of Neurology (Chicago), 44, 634-639.

Potaznik, W. & Kozol, N. (1992). The incidence of ocular disturbances in people with chronic fatigue syndrome. Optometry and Vision Science, 10, 811-814.

Qavi, H.B., Xu, B., Green, M.T., Lusso, P., Pearson, G., & Ablashi, D.V. (1996). Morphological and ultrastructual changes induced in corneal epithelial cells by HIV-1 and HHV-6 in vitro. Current Eye Research, 15(6), 597-604.

Rae, C., Lee, M.A., Dixon, R.M., Blamire, R.M., Thompson, C.H., Styles, P., Talcott, J., Richardson, A., & Stein, J. (1998). Metabolic anomalies in developmental dyslexia detected by 1H magnetic resonance spectroscopy. The Lancet, 351, 1849-1852.

Rasmussen, P. & Gillberg, C. (1999). AD(H)D, hyperkinetic disorders, DAMP, and related behavior disorders. In K. Whitmore, H. Hart, & G. Willems (Eds.), A neurodevelopmental approach to specific learning disorders (pp.134-157), London, UK: MacKeith Press.

Reichelt, K.L., Ekrem, J., & Scott, H. (1990). Gluten, milk proteins and autism: Dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition, 42, 1-11.

Reichelt, W.H., Knivsberg, A., Nødland, M., Stensrud, M., & Reichelt, K.L. (1997). Urinary peptide levels and patterns in autistic children in seven countries, and the effect of dietary intervention after 4 years. Developmental Brain Dysfunction, 10, 44-55.

Riding, R.J. & Pugh, J.C. (1977). Iconic memory and reading performance in nine year old children. British Journal of Educational Psychology, 47, 132-137.

Robinson, G.L. & Conway, R.N.F. (2000). Irlen lenses and adults: A small scale study of reading speed, accuracy, comprehension and self-image. Australian Journal of Learning Disabilities, 5(1), 4-13.

Robinson, G.L. & Foreman, P.J. (1999a). The effect of Irlen coloured filters on eye movement. Behavioural Optometry, 7(4), 5-18.

Robinson, G.L. & Foreman, P.J. (1999b). Scotopic Sensitivity/Irlen Syndrome and the use of coloured filters: A long-term placebo controlled and masked study of reading achievement and perception of ability. Perceptual and Motor Skills, 89, 83-113.

Robinson, G.L., Foreman, P.J., & Dear, K.G.B. (1996). The familial incidence of symptoms of Scotopic Sensitivity/Irlen Syndrome. Perceptual and Motor Skills, 83, 1043-1055.

Robinson, G.L., Roberts, T.K., McGregor, N.R., Dunstan, R.H., & Butt, H. (1999). Understanding the causal mechanisms of visual processing problems: A possible biochemical basis for Irlen Syndrome? Australian Journal of Learning Disabilities, 4(4), 21-29.

Rosenhall, V., Johannson, G., & Orndahl, G. (1987). Eye motility dysfunction in chronic primary fibromyalgia with dysesthenia. Scandinavian Journal of Rehabilitation Medicine, 19(2), 139-145.

Rosenhall, V., Johannson, G., & Orndahl, G. (1996). Otoneurological and audiologic findings in fibromyalgia. Scandinavian Journal of Rehabilitation Medicine, 28(4), 225-232.

Rowe, K.S. & Rowe, K.J. (1994). Synthetic food coloring and behavior: A dose response effect in a double-blind placebo-controlled repeated-measures study. Journal of Pediatrics, 125, 691-698.

Skottun, B.C. (2000). The magnocellular deficit theory of dyslexia: The evidence from contrast sensitivity. Vision Research, 40, 111-127.

Skottun, B.C. & Parke, L.A. (1999). The possible relationship between visual deficits and dyslexia: Examination of a critical assumption. Journal of Learning Disabilities, 32(1), 2-5.

Shapiro, K.L., Raymond, J.E., & Arnell, K.M. (1994). Attentional to visual pattern information produces the attentional blink in rapid serial visual presentations. Journal of Experimental Psychology: Human Perception and Performance, 20(2), 357-371.

Shattock, P., Kennedy, A., Rowell, F., & Berney, T. (1990). Role of neuropeptides in autism and their relationships with classical neurotransmitters. Brain Dysfunction, 3, 328-345.

Singh, V.K., Lin, S.X., & Yang, V.C. (1998). Serological association of measles virus and human herpes virus-6 with brain autoantibodies in autism. Clinical Immunology and Immunopathology¸89(1), 105-108.

Solan, H.A., Ficarra, A., Brannan, J.R., & Rucker, F. (1998). Eye movement effiency in normal and reading disabled elementary school children: Effects of varying luminance and wavelength. Journal of the American Optometric Association, 69(7), 455-464.

Solman, R.T., Cho, H., & Dain, S.J. (1992). Colour mediated grouping effects in good and disabled readers. Ophthalmic and Physiological Optics, 11, 320-327.

Solman, R.T., Dain, S.J., & Keech, S.L. (1991). Color-mediated contrast sensitivity in disabled readers. Optometry and Vision Science, 68, 331-337.

Spafford, C.S. & Grosser, G.S. (1991). Retinal differences in light sensitivity between dyslexic and proficient reading children: New prospects for optometric input in diagnosing dyslexia. Journal of the American Optometric Association, 62, 610-615.

Stein, J. & Talcott, J. (1999). Impaired neuronal timing in developmental dyslexia: The magnocellular hypothesis. Dyslexia, 5, 55-77.

Stevens, L.J., Zentall, S.S., Abate, M.L., Kuczek, T., & Burgess, J.R (1996). Omega-3 fatty acids in boys with behavior, learning and health problems. Physiology and Behavior, 59, 915-920.

Stordy, B.J. (1995). Benefits of docosahexaenioc acid supplements to dark adaption in dyslexics. The Lancet, 346, 385.

Stordy, B.J. (1998). Fatty acid supplementation and dyslexia. Seminar at the Department of Biological Sciences, University of Newcastle, 24 March, 1998.

Suhadolnik R.J., Reichenbach N.L., Hitzges P., Sobow, R.W., Peterson, D.L., Henry, B., Ablashi, D.V., Muller, W.E., Schroder, H.C., & Carter, W.A. (1994). Upregulation of the 2-5A Synthetase/RNase L pathway associated with chronic fatigue syndrome. Clinical Infectious Diseases, 18, S96-S104.

Suhadolnik R.J., Peterson D.L., O'Brien K., Cheney, P.R., Herst, C.V., Reichenbach, N.L., Kon, N., Horvath, B.E., Iacono, K.T., Adelson, M.E., De Meirleir, K., De Becker, P., Charubala, R., & Pfeiderer, W. (1997). Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. Journal of Interferon and Cytokine Research, 17, 377-85.

Torgesen, J.K. (1998). Learning disabilities: An historical and conceptual overview. In B. Wong (Ed.), Learning about learning disabilities, (pp.3-34), San Diego: Cal., Academic Press.

Tyrrell, R., Holland, K., Dennis, D., & Wilkins, A. (1995). Coloured overlays, visual discomfort, visual search and classroom reading. Research in Reading, 18, 10-23.

Uhlig, T., Merkenschlager, A., Brandmaier, R., & Egger, J. (1997). Topographic mapping of brain electrical activity in children with food-induced attention deficit hyperactivity disorder. European Journal of Pediatrics, 156, 557-561.

Valdois, S., Gerard, C., Vanault, P., & Dugas, M. (1995). Perceptual developmental dyslexia: A visual attentional account? Cognitive Neuropsychology, 12(1), 31-67.

Vedelago, L.J. (1994). Visual dysfunction in chronic fatigue syndrome: Behavioral optometric assessment and management. Behavioral Optometry, 5(4), 11-18.

Whiteley, P., Rodgers, J., Savery, D., & Shattock, P. (1999). A gluten-free diet as an intervention for autism and associated spectrum disorders: Preliminary findings. Autism, 3(1), 46-65.

Whiting, P., Robinson, G.L., & Parrot, C.F. (1994). Irlen coloured filters for reading: A clinical study. Australian Journal of Remedial Education, 26(3), 13-19.

Wilkins, A.J., Jeans, R.J., Pumfrey, P.D., & Laskier, M. (1996). Rate of reading test: Its reliability and its validity in the assessment of the effects of coloured overlays. Opthalmological and Physiological Optics, 16(6), 491-497.

Wilkins, A.J. & Lewis, E. (1999). Coloured overlays, text and texture. Perception, 28, 641-650. Wilkins, A.J. & Wilkinson, P. (1991). A tint to reduce eye strain from fluorescent lighting? Preliminary observations. Ophthalmological and Physiological Optics, 11, 172-175.

Williams, M.C. & Lovegrove, W.J. (1992). Sensory and perceptual processing in reading disability. In J. Brannan (Ed.), Application of parallel processing in vision (pp.263-302), Amsterdam: Elsevier Science.

Willows, D.M. (1998). Visual processing in learning disabilities. In B. Wong (Ed.), Learning about learning disabilities (2nd Ed.) New York: Academic Press.

Wong, B.Y.L. (1986). Metacognition and special education: A review of a view. Journal of Special Education, 20, 9-29.

Wood, L.A. & Cooper, D.S. (1992). Autoimmune thyroid disease, left handedness and developmental dyslexia. Psychoneuroendocrinology, 17, 95-99

 

Appendix A: Assessment of severity of symptoms/degree of improvement

Name:____________________________ Date: _________

Scores

0 = not at all
1 = a little bit
2 = moderately
3 = quite a lot
4 = extremely

a. Eye strain/fatigue/headaches while reading

- eyes hurt, burn, itch, feel tired
- become tired while reading
- headaches when reading
- have to make an effort to see words clearly

Severity of symptoms 0 1 2 3 4

Degree of improvement 0 1 2 3 4

b. Print distortions/clarity while reading

- words move/double/merge
- words go blurry/fuzzy/shadowy
- words come off the page
- have halos around them

Severity of symptoms 0 1 2 3 4

Degree of improvement 0 1 2 3 4

c. Photophobia/light sensitivity when reading

- fluorescent lighting uncomfortable or too bright
- white patterns and rivers in print
- glare from white page

Severity of symptoms 0 1 2 3 4

Degree of improvement 0 1 2 3 4

d. Reading speed/errors while reading/duration of reading

- word-by-word reading
- skipping/guessing words
- re-reading
- understand what is read
- duration of reading

Severity of symptoms 0 1 2 3 4

Degree of improvement 0 1 2 3 4